SSA
AYTU icon

Schonfeld Strategic Advisors’s AYTU BioPharma AYTU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-845
Closed -$18K – 2536
2022
Q1 		$18K Sell
845
-5
-0.6% -$124 ﹤0.01% 2399
2021
Q4 		$23K Sell
850
-160
-16% -$6.92K ﹤0.01% 1983
2021
Q3 		$58K Sell
1,010
-298
-23% -$22.4K ﹤0.01% 1989
2021
Q2 		$131K Sell
1,308
-47
-3% -$5.51K ﹤0.01% 1760
2021
Q1 		$206K Buy
+1,355
New +$215K ﹤0.01% 1488

Other funds holding AYTU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Schonfeld Strategic Advisors's AYTU Position: Q2 2022 in Review

Schonfeld Strategic Advisors sold out of AYTU BioPharma (AYTU) in Q2 2022, closing a stake of 845 shares — an estimated $18K sold.

Schonfeld Strategic Advisors first reported a position in AYTU in Q1 2021 and held it in 5 quarters. The position peaked at $206K in Q1 2021. 30 funds tracked by Wall St. Rank hold AYTU as of Q2 2022.

  • Schonfeld Strategic Advisors reported no remaining AYTU BioPharma position as of Q2 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 845 AYTU BioPharma shares in Q2 2022, an estimated $18K.
  • Schonfeld Strategic Advisors first reported a position in AYTU BioPharma in Q1 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's AYTU BioPharma position peaked at $206K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.